STUDYID,DOMAIN,VISITNUM,VISIT,ARMCD,TVSTRL,TVENRL
3110-103-002,TV,-2.0,Day -14 to -1,,Informed Consent Signed,Randomized
3110-103-002,TV,-1.0,Period 1 Day -1,,1 Day prior to dosing in Period 1,Dosing: Period 1
3110-103-002,TV,1.0,Period 1 Day 1,,Dosing: Period 1,1 Day after start of element
3110-103-002,TV,2.0,Period 1 Day 2,,1 Day after start of element,2 Days after start of element
3110-103-002,TV,7.0,Period 2 Day 7,,1 Day prior to dosing in Period 2,Dosing: Period 2
3110-103-002,TV,8.0,Period 2 Day 8,,Dosing: Period 2,1 Day after start of element
3110-103-002,TV,9.0,Period 2 Day 9,,1 Day after start of element,2 Days after start of element
3110-103-002,TV,24.0,Period 3 Day 14,,1 Day prior to dosing in Period 3,Dosing: Period 3
3110-103-002,TV,25.0,Period 3 Day 15,,Dosing: Period 3,1 Day after start of element
3110-103-002,TV,26.0,Period 3 Day 16,,1 Day after start of element,2 Days after start of element
3110-103-002,TV,27.0,End of Treatment,,2 Days after last dose,1 Day after start of element
3110-103-002,TV,31.0,Follow Up,,30 Days after last dose,1 Day after start of element
3110-103-002,TV,98.0,Early Term,,1 Day after end of study,1 Day after start of element
